30048-07-8

Upstream product

• 10429-07-9 3β-tosyloxy-5α-androstan-17-one 
• 481-29-8 Epiandrosterone 
• 53-43-0 dehydroepiandrosterone 

Downstream Products

• 1142951-32-3 3α-hydroxy-4β-[(phenylmethyl)amino]-5α-androstan-17-one 
• 1142951-34-5 3α-hydroxy-4β-(methylphenylamino)-5α-androstan-17-one 
• 1142951-37-8 3α-hydroxy-4β-[(2-hydroxyphenyl)amino]-5α-androstan-17-one 
• 1142951-33-4 3α-hydroxy-4β-(phenylamino)-5α-androstan-17-one 
• 1142951-36-7 3α-hydroxy-4β-[(4-methoxyphenyl)amino]-5α-androstan-17-one 
• 1142951-35-6 3α-hydroxy-4β-[(4-methylphenyl)amino]-5α-androstan-17-one 
• 1142951-26-5 3α-hydroxy-4β-(cyclohexylamino)-5α-androstan-17-one 

Relevant academic research and scientific papers

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

Described herein are neuroactive steroids of the Formula (I): (Formula (I)) or a pharmaceutically acceptable salt thereof; wherein R1a and R1b are as defined herein. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. The present invention also provides pharmaceutical compositions comprising a compound of the present invention and methods of use and treatment, e.g., such for inducing sedation and/or anesthesia.